Foreign markets
USP Group develops its export activities on the markets of Central East and East Europe through its specialised company named EU Pharmacia. The company possesses its own representative offices on Lithuanian, Ukrainian and Bulgarian markets.
The company is present on all markets in the biggest pharmaceutical categories, such as pain-killers, cold & flu and gastric. Its portfolio also contains allergic drugs and vitamins. The company actively supports its trademarks by TV advertising and other marketing activities, due to which it constantly improves its position on the market. USP also cares about education of consumers, develops knowledge about self-treatment and the use of modern drugs.
Good sale results on the present markets encourage our company to expand onto new markets of East Europe. At the moment, registration is in progress in several countries of this region. The long-term goal of USP is to gain the leader position in the biggest pharmaceutical categories on the foreign markets.
The USP representative office started its activity in Ukraine in 2003. Launching Ibuprom and Gripex brands on the Ukrainian market, USP has become a major player in two main categories in OTC market - analgesics and cold & flu categories...
The Bulgarian trade representative office was established in 2007 in Sofia and since that time USP Bulgaria is continuously growing. Achieving position 148 within the OTC companies in 2008, the Bulgarian branch of USP went up to No 46 in 2009*...
Since establishment in Y2003, USP Lithuania was growing at double digit numbers each year. In Y2009 becoming Nr10 OTC company in the country (Source: IMS). All brands of the USP Lithuania: Gripex, Apap, Ibuprom and Verdin are among top selling brands at their categories...
